PIN40 Cost-Effectiveness of Boceprevir-Based Treatment of Chronic Genotype 1 Hepatitis C Virus (HCV) Infection From the Perspective of the German Statutory Health Insurance (SHI)
Abstract
Authors
B. Becker J. Chhatwal S. Ferrante E.H. Elbasha K.J. Krobot